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OBJECTIVES We sought to understand the genomic program leading to collateral vessel formation.
BACKGROUND Recently, technology has advanced to the point that it is now possible to elucidate the large
array of genes that must be expressed, as well as the temporal expression pattern, for the
development of functionally important collateral vessels. In this investigation, we used
deoxyribonucleic acid array expression profiling to determine the time course of differential
expression of 12,000 genes after femoral artery ligation in C57BL/6 mice.
METHODS Ribonucleic acid was extracted from the adductor muscle, which showed no signs of ischemia.
Sampling was at baseline, 6 h, and 1, 3, 7, and 14 days after femoral artery ligation or sham
operation.
RESULTS Femoral artery ligation caused the differential expression (2-fold) of 783 genes at one or
multiple time points: 518 were induced and 265 were repressed. Cluster analysis generated
four temporal patterns: 1) early upregulated (6 to 24 h)—immediate early transcriptional
factors, angiogenesis, inflammation, and stress-related genes; 2) mid-phase upregulated (day
3)—cell cycle and cytoskeletal and inflammatory genes; 3) late upregulated (days 7 to
14)—angiostatic, anti-inflammatory, and extracellular matrix-associated genes; and 4) down-
regulated—genes involved in energy metabolism, water channel, and muscle contraction.
Microarray data were validated using quantitative reverse transcription polymerase chain
reaction.
CONCLUSIONS This study documents the large number of genes whose differential expression and temporal
functional clustering appear to contribute to collateral formation. These results can serve as
a genomic model for arteriogenesis and as a database for developing new therapeutic
strategies. (J Am Coll Cardiol 2004;43:474–82) © 2004 by the American College of
Cardiology Foundationt
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ihe development of collateral vessels, referred to as arterio-
enesis, is a complex process requiring the action of multiple
enes expressed in an appropriate time-dependent manner.
he process is undoubtedly tightly regulated by multiple
actors, some of which include the appropriately timed
xpression of both arteriogenic and arteriostatic factors, the
elative balance of which changes over the course of time
1).
Understanding the genomic program leading to collateral
ormation is of fundamental importance to develop insights
nto what factors are responsible for the highly variable
bility that different patients have to form collaterals, as well
s optimal therapeutic strategies designed to enhance col-
ateral formation. Despite its importance, little is known
bout the array of genes that must be expressed, or their
emporal expression pattern, for functionally important
ollaterals to develop.
Recent advances in microarray technology provide the
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t the transcriptional level of thousands of genes simulta-
eously (2). In this regard, a gene chip is commercially
vailable for transcriptional profiling that contains 12,000
ouse genes. Fortunately, one of the better models com-
only used for arteriogenesis research is a murine model of
cute hindlimb ischemia. Thus, the animal model and
echnology are available that make possible sophisticated
ene expression studies. Therefore, we investigated the
emporal profiles of global gene expression in muscle sur-
ounding developing collaterals during the response to acute
indlimb ischemia in the mouse, with the goal of obtaining
more comprehensive understanding of the genomic pro-
ram of arteriogenesis.
ETHODS
nimal model. Twelve-week-old male C57BL/6 mice
ere used for the experiments. Animals either underwent
eft femoral artery ligation or a sham operation. Mice were
nesthetized with a mixture of ketamine (40 mg/kg) and
ylazine (100 mg/kg). A skin incision was performed on the
edial aspect of the left thigh. After careful dissection of
he vein and nerve, the femoral artery was ligated and cut
mmediately distal to the inguinal ligament and proximal to
he popliteal bifurcation site (Fig. 1). No branches were
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roup, the femoral artery was dissected free but not ligated.
After surgery, all animals were closely monitored and
acrificed at five different time points. The entire adductor
uscle was used for array studies and Western blotting. The
tudy protocol was approved by the Animal Care and Use
ommittee of the MedStar Research Institute.
issue collection and ribonucleic acid (RNA) preparation.
he temporal expression profiles were analyzed at five time
oints (baseline, 6 h, and 1, 3, 7, and 14 days after surgery),
ecause the majority of flow recovery occurs during this
eriod. Left adductor muscles were harvested from groups
ubjected to femoral artery ligation and from sham-operated
roups (n  4 animals per group per time point). Tissue
amples were immediately frozen in liquid nitrogen and
tored at 80°C. Total RNA was extracted from pools of
our mice using Trizol reagent (Invitrogen, Carlsbad, Cal-
fornia), according to the manufacturer’s instructions. The
NA was cleaned using a RNeasy mini-kit (Qiagen, Va-
Abbreviations and Acronyms
cDNA  complementary deoxyribonucleic acid
ENA-78  epithelial neutrophil activating protein-78
HIF1  hypoxia-inducible factor-1
Hmox  heme oxygenase
HSP  heat shock protein
IL  interleukin
IP  interferon-gamma-inducible protein
MCP1  monocyte chemoattractant protein-1
MIG  monokine induced by interferon-gamma
MIP  macrophage inflammatory protein
MMP12  metalloelastase (metalloproteinase-12)
MT1  metallothionein-1
RNA  ribonucleic acid
RT-PCR  reverse transcription-polymerase chain
reaction
igure 1. Mouse hindlimb model. Schematic drawing of the femoral artery
igation sites. The femoral artery was ligated and cut immediately distal to
he inguinal ligament and proximal to the popliteal bifurcation site. TheDntire adductor muscle was used for array studies and Western blotting.encia, California) and stored at 80°C. The RNA concen-
rations were obtained by measuring absorbance at 260 nm,
nd its integrity was verified with a 2% agarose mini-gel.
icroarray analysis. Double-stranded complementary de-
xyribonucleic acid (cDNA) was synthesized from 8 g
otal RNA. For the first cDNA strand synthesis, oligo(dT)
rimers were annealed to the RNA, and extension by reverse
ranscriptase was performed in the presence of deoxyoligo-
ucleotides. The second strand was synthesized using de-
xyribonucleic acid polymerase I and purified using phase-
ock gels-phenol/chloroform extraction, followed by ethanol
recipitation.
In vitro transcription, using double-stranded cDNA as a
emplate in the presence of biotin-labeled ribonucleotides,
as performed by using an Enzo in vitro transcription kit
Enzo Diagnostics, Inc., Farmingdale, New York). Biotin-
abeled complementary RNA was purified, fragmented, and
ybridized to Affymetrix Murine Genome U74Av2 chips
Affymetrix, Santa Clara, California), which contains
12,000 mouse genes. Hybridization, washing, antibody
mplification, staining, and scanning of probe arrays were
erformed according to the Affymetrix Technical Manual.
Scanned raw data were processed with Affymetrix Gene-
hip version 5.0 software. The average intensity value for
ach probe set, which directly correlates to messenger RNA
bundance, was calculated as an average of fluorescence
ifferences for each perfectly matched probe versus single-
ucleotide-mismatched probe. This software also gives each
ene a qualitative assessment of “absent” or “present” calls.
ata sets on each GeneChip were normalized by scaling
otal chip fluorescence intensities to a common value of 800
efore comparison. All data were imported into GeneSpring
ersion 5.0 software (Silicon Genetics, Redwood City,
alifornia) for further analysis. The fold changes of each
ene at different time points were calculated based on the
ormalized values and represented as relative to baseline
day 0). We selected the genes with a 2-fold change over
aseline in at least one time point. A value of differential
ene expression 2-fold at one or multiple time points
etween the femoral artery ligation and sham-operated
roups was considered as significant. Genes that were
nduced or repressed at similar levels in both groups were
xcluded from the analysis. Cluster analysis was performed
o identify families of genes with a similar time-dependent
xpression.
eal-time reverse transcription polymerase chain reac-
ion (RT-PCR). To validate the microarray data, expres-
ion of three selected genes (monocyte chemoattractant
rotein-1 [MCP1], metallothionein-1 [MT1], and met-
lloelastase [or metalloproteinase; MMP12]) were analyzed
sing quantitative real-time RT-PCR. Complementary
NA was synthesized from 200 ng total RNA in a 20-l
eaction using TaqMan reverse transcription reagents (Ap-
lied Biosystems, Branchburg, New Jersey). Real-time RT-
CR was performed with an ABI PRISM 7700 Sequence
etection System instrument and software (PE Applied
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Gene Expression After Acute Hindlimb Ischemia February 4, 2004:474–82able 1. Representative Genes Differentially Regulated Between Mice With Femoral Artery Ligation and Sham Control Operation
Gene
Accession
Number
Femoral Artery Ligation Sham Operation
6 h 1 d 3 d 7 d 14 d 6 h 1 d 3 d 7 d 14 d
Angiogenesis
yr61 M32470 3.10 2.04 3.03 3.01 1.66 1.28 2.73 2.89 2.51
DGF D63707 2.97 2.01 2.67 1.94 1.41 2.09
P10 M33266 2.69 2.89 4.10 2.57 3.17 3.16 1.64
CP1 M19681 9.94 28.8 12.5 3.61 2.61 7.67 10.8 6.11 1.90
IG M34815 1.25 0.88 2.77 0.81 0.83 0.72
MP12 M82831 5.44 18.0 58.9 6.21 2.06
IGF X80171 3.46 1.76 1.94
GF1 AJ009862 15.7 21.7
Cell Growth and Survival
cnb1-rs1 X64713 53.8 19.5 31.3
dc2a M38724 4.12 2.61 1.97
dkn1a AW048937 3.03 5.38 2.36 3.45 2.48 2.78 2.30 1.72 1.72
cn2 X81627 2.56 60.6 10.2 0.97 1.02 5.46 8.64 5.57
ki67 X82786 2.81 2.62 1.70 1.34
ts1 M36579 0.73 3.50 7.10 3.79 3.75 1.18 4.83 3.46 3.30 1.19
mox1 X56824 3.23 8.52 5.21 1.58 1.71 5.34 2.85 3.29 1.24 0.96
SP70-3 M12571 2.11 5.36 0.67 0.95 0.79 1.01 1.07 0.69 0.75 0.62
t1 V00835 8.14 40.8 20.4 1.94 0.76 17.9 11.37 17.4 0.79
GP-1 AF037437 42.1 29.5 27.4 47.6 59.6
ac1 X9504 4.26 77.8 58.7 14.4
Cell Shape and Motility
rp2 D88792 3.69 8.74 5.13 2.80 3.32 4.38
mnb1 M35253 3.52 2.23 3.62 2.41 1.08 1.68
yhse M74753 1.79 54.0 9.46 2.99 3.33
yh8 M12289 1.61 1.15 24.1 11.1 2.29 1.49 1.47 3.54 2.64
yla M19436 0.81 1.43 32.6 14.3 1.08 2.87 6.76 1.62
ubb5 X04663 0.86 2.14 3.53 2.72 2.12 0.82 1.77 2.22 1.48 0.71
lc2 M91602 0.63 0.55 0.04 0.07 0.12 0.50 0.94 0.12 0.46 0.29
yhcb AJ223362 0.67 0.73 0.11 0.11 0.19 0.63 1.46 0.30 0.61 0.42
pm5 U04541 0.64 0.74 0.14 0.14 0.18 0.55 1.14 0.33 0.55 0.35
Cytokines and Inflammation
D14 X13333 2.33 8.23 2.53 2.56 2.25 2.04 3.29 1.91 1.38
D68 X68273 2.47 5.05 4.41 3.23 2.41 3.06 1.34
NA78 U27267 9.57 266 36.6 9.10 27.4 60.7 34.3
p49 M65027 2.29 14.9 6.42 5.23 4.89 1.69 4.98 3.28 2.22 0.91
p49b U05265 2.53 9.81 4.25 3.78 3.76 3.08 5.55 2.71 1.60
cp2 U20159 2.57 3.69 2.16 1.13 1.02 1.63 3.63 1.07
L1 M15131 240 49.9 107 50.8
L6 X54542 255 211 161 114 150 161
ipo1 M69260 0.82 1.44 1.98 2.14 2.69 0.69 1.84 1.90 1.84 0.81
CP3 X70058 4.96 34.5 15.2 4.33 2.36 5.49 18.28 7.55 2.12 0.44
IP1 J04491 6.75
IP2 X53798 52.3 394 24.9 6.43 31.8 28.2 112 24.1
RP8 M83218 2.01 10.3 2.74 0.53 1.04 1.12 3.49 4.30 0.14
Extracellular Matrix
gn X53928 0.99 1.12 2.71 6.92 4.70 0.78 1.59 1.71 3.19 1.09
mp1 AA518586 2.38 1.57 1.87 2.38 3.11 1.57 1.87
tss AJ223208 0.25 1.47 5.17 5.38 4.35 0.32 2.35 3.24 1.93 0.52
ollla2 X58251 0.95 1.10 2.10 6.35 7.35 0.90 1.26 1.73 3.97 1.14
oll3a1 AA655199 1.49 1.20 5.30 9.94 12.8 0.69 2.38 5.28 7.42 1.93
Continued on next page
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anufacturer’s recommendation. The principle of real-
ime RT-PCR has been described in detail elsewhere (3).
rimer and probe sequences were chosen using sequences
n the GenBank: MCP1 forward (5-GAGCATCCACG-
GTTGGCT-3), reverse (5-TGGTGAATGAGT-
GCAGCAGGT-3), probe ([6-FAM]-AGCCAGAT-
CAGTTAACGCCCCACT-[TAMRA-FAM]); MT1
orward (5-CCTGCTCCACCGGCG-3), reverse (5-GC-
GACACAGCCCTGGG-3), probe ([6-FAM]-CTG-
TGCTCCTGCTGTCCCGTGTG-[TAMRA-FAM];
able 1. Continued
Gene
Accession
Number
Femoral Artery Ligation
6 h 1 d 3 d 7
PX-1 AF07773 18.0 19
gmn AJ000990 1.17 2.99 5.58 6
glap D00613 0.81 1.52 1.24 4
MP3 X66402 8.30 7.86 3
MP13 X66473 1.78 11
MP14 AF022432 1.05 0.84 1.35 2
SF-2 D13664 0.94 1.22 3.12 25
AI-1 M33960 3.34 5.57 2.13 2
pp1 X13986 11.1 32.7 14
nc X56304 1.65 3.35 2.99 19
Met
bca1 X75926 2.46 3
cadm U07159 0.86 0.83 0.48 0
poe D00466 0.67 0.83 2.58 5
ox8b U15541 0.62 0.76 0.33 0
yp1b1 X78445 3.03 3.22 2
lut-4 M23383 0.98 0.54 0.43 0
p1 AA726364 0.56 0.65 0.41 0
dha-1 M76727 0.68 0.88 0.34 0
Sig
ctivin X69620 21.2 3.54
dam8 X13335 60.0 40.0 18
it D85785 12.4 13
D116 M85078 6.81 6.27 8
mr1 X93328 5.10 6
kbp10 L07063 2.25 1.76 2.43 3
na12 M63659 2.80 4
tgax AI035495 3
ld3 AF02612 2.10 3
isp1 AF10077 2.01 8
Tran
lrp AF041847 0.90 36.3 16.6 12
-myc L00039 2.61 6.71 3.09 2
os V00727 17.9 12.8 8.15 6
unb U20735 139 74.7 44.7 27
er2 M59821 3.06 2.70 1.62 1
coa1 U64828 2.63 0.99 1.10 1
nf4 AV37235 12.1
Other
q1 L02914 0.99 0.97 0.82 0
qp4 U88623 0.78 0.09 0.13 0nd MMP12 forward (5-GAGGCAGAAACGT- tGACTAAAAGT-3), reverse (5-GTTCATGAA-
AGCAACAAGGAAGA-3), probe [6-FAM]-TTT-
AAGGCACAAACC-[TAMRA-FAM]). Quantitative
CR was performed in 96 sample plates. The cDNA equiva-
ent of 100 ng total RNA/tube containing TaqMan PCR
niversal Master Mix (Applied Biosystems), 100 nmol/l
robe, and 200 nmol/l of each primer was used. As a control
or RNA integrity and for assay normalization, 18S ribosomal
NA was amplified using a TaqMan ribosomal RNA control
eagents kit (Applied Biosystems). Gene expression levels were
ompared using the Ct method, as follows: Ct1  [Ct of
Sham Operation
14 d 6 h 1 d 3 d 7 d 14 d
15.0
4.40 0.88 2.98 5.20 2.07 1.22
2.65 0.62 1.75 1.26 1.65 0.61
5.08 9.40 14.3 3.67
8.15
3.15 1.14 1.26 1.16 1.85 1.21
18.2 0.52 1.35 2.89 10.7 1.26
1.33 2.7 1.36 1.92 1.25 0.71
19.5 10.8 9.45 2.81
8.78 1.64 4.36 3.82
sm
2.57 1.67 1.54 2.66
0.56 0.81 1.10 0.56 0.92 0.72
4.17 0.61 0.94 2.81 2.79 1.26
0.36 0.84 1.13 0.54 1.05 0.68
2.01 2.36 3.29
0.46 1.11 0.70 0.48 0.85 0.90
0.42 0.52 1.0 0.85 0.69 0.49
0.48 0.70 0.62 0.53 0.95 0.61
g
25.0
13.6
9.24 4.51
2.71 2.62 4.34
3.53 1.80 2.03 2.05
3.38
3.54
2.23
4.15 2.16 2.47
tion
2.45 4.05 8.93 19.6 3.83 0.62
0.88 2.67 2.38 3.91 1.64
3.29 5.68 10.5 13.1 16.1 2.51
140 31.4 24.3
0.96 1.47 1.55 1.71 1.74 0.70
1.61 1.37 1.32 1.5
tions
0.59 1.71 1.14 0.83 1.06 1.07
0.39 0.59 0.11 0.17 0.57 0.43d
.9
.49
.21
.30
.6
.55
.9
.30
.6
.85
aboli
.23
.46
.90
.46
.51
.35
.42
.43
nalin
.7
.2
.47
.61
.69
.03
.81
.56
.70
scrip
.8
.20
.38
.4
.46
.32
Func
.49
.12arget gene in RNA from ligated mice] [Ct of 18S in RNA
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Gene Expression After Acute Hindlimb Ischemia February 4, 2004:474–82rom ligated mice]; and Ct2  [Ct of target gene in RNA
rom sham mice]  [Ct of 18S in RNA from sham mice].
xpression levels were calculated by 2exp([Ct1  Ct2]).
estern blot analysis of tissue hypoxia-inducible factor
HIF)1-alpha levels. Adductor and calf muscles were lysed
n ice-cold buffer, and 40 g protein was separated using
0% sodium dodecyl sulfate polyacrylamide gel electro-
horesis. After transferring onto nitrocellulose membrane,
he blots were incubated with a goat anti-mouse HIF1-
lpha antibody (Santa Cruz Biotechnology, Santa Cruz,
alifornia) and visualized with enhanced chemilumines-
ence (Pierce, Rockford, Illinois).
ESULTS
total of 783 genes showed at least twofold differential
xpression between the femoral artery ligation and sham
roups at one or multiple time points: 518 were induced and
65 were repressed. The largest number of differentially
egulated genes was observed seven days after surgery;
epresentative genes are shown in Table 1. Complete lists of
pregulated and downregulated genes are presented as data
upplements. (For Appendices 1 and 2, please see the
ebruary 4, 2004, issue of JACC at www.cardiosource.com/
acc.html.) Genes were classified into eight groups accord-
ng to their predominant function, although some genes
ere difficult to classify because they exhibit multiple
ominant functions.
ifferential gene expression according to function. A
umber of angiogenesis-related genes, including cysteine-rich
rotein-61, hepatoma-derived growth factor, MCP1, pla-
ental growth factor, and transforming growth factor-beta,
ere differentially upregulated in the femoral artery ligation
roup as compared with the sham group (Table 1). How-
ver, some genes known to be related to angiogenesis
angiopoietin 1, fibroblast growth factor 1, endothelial nitric
xide synthase, FMS-related tyrosine kinase 1, hypoxia
nducible factor 1 alpha, tyrosine kinase with Ig and EGF
omology domains, and vascular endothelial growth factor
and C) were undetectable or not significantly changed,
nd other such genes (vascular endothelial growth factor A
nd D) were similarly upregulated in both groups.
It is interesting to note a significant upregulation of genes
hought to exert angiostatic activities (interferon-gamma–
nducible protein-10, monokine induced by interferon-
amma [MIG], and MMP12) during the late time points
fter femoral artery ligation. Stress-related genes, including
eme oxygenase-1 (Hmox), heat shock protein (HSP)70-3,
nd MT1, were highly upregulated during the early time
oints.
Inflammatory response-related genes comprised the largest
ene cluster that was upregulated. Although upregulated in
oth groups, the genes exhibited higher expression levels for
onger times in the femoral artery ligation versus sham
roup. The epithelial neutrophil activating protein
ENA)-78 profile showed a peak level at one day after curgery. Interleukin (IL)-1-beta, IL-6, MCP1, macrophage
nflammatory protein (MIP)1-alpha, and MIP2 expression
lso demonstrated early peak levels after femoral artery
igation, and then slowly declined. Markers for inflamma-
ory cell infiltration were also detected: neutrophil markers
CD14, MRP8) appearing at 6 h, followed by those for
acrophages (CD14, CD68), mast cells (Gp49, Gp49b),
nd lymphocytes (Lcp2). The most highly expressed cyto-
ines (10-fold induction) were ENA-78, IL-1-beta, IL-6,
CP1, MCP-3, and MIP2.
Cytoskeletal genes, including cysteine-rich protein 2 (dou-
le LIM protein-1) and tubulin were slowly induced and
emained at high levels throughout the study period. Genes
ncoding contractile proteins were either enhanced (Myhse,
yh8, Myla) or repressed (Mlc2, Tpm5).
The expression of extracellular matrix-associated genes
ccurred at late time points. The genes in this category
ncluded those encoding several types of collagen, biglycan,
tss (cathepsin S), Mglap (matrix Gla protein), and matrix
etalloproteinases (MMP-3, MMP12, MMP14). The
enes encoding CPX-1 (metallocarboxypeptidase),
steoblastic-specific factor-2, and Spp1 (osteopontin) man-
fest similar time trends of expression.
Genes encoding proteins involved in energy metabolism
Acadm, Cox8b, Glut-4, Lp1, Pdha-1) were generally
epressed across the time course of the experiment, whereas
he genes involved in cholesterol transport (ABCA1 and
poE) were slightly upregulated. There were a number of
enes corresponding to expressed sequence tags that were
ifferentially expressed (data not shown).
lustering gene expression patterns. The expression pro-
les were clustered according to similarity of temporal
xpression patterns, using k-means cluster analysis (Fig. 2).
ARLY INDUCTION. Genes that were rapidly induced at
arly phase (peak levels at 6 to 24 h) included immediate
arly transcriptional factors (Fos, Junb, Ler2), followed by
enes associated with angiogenesis and inflammation, as
ell as stress-related genes.
ID-PHASE INDUCTION. Genes that were upregulated at
id-phase, defined as those genes whose peak expression
ccurred at day 3, included genes associated with cell cycle
egulation, cytoskeletal-related genes, and additional
nflammation-related genes.
ATE-PHASE INDUCTION. Genes that were upregulated at
he late phase, defined as those genes whose peak expression
ccurred at days 7 to 14, included genes associated with
ngiostatic, anti-inflammatory (lipo1), cytoskeletal, and ex-
racellular matrix-associated effects.
OWNREGULATION. Genes that were downregulated
0.5-fold) after surgery included those genes involved in
nergy metabolism, water channels (Aq1, Aqp4), and mus-
le contractions.
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February 4, 2004:474–82 Gene Expression After Acute Hindlimb Ischemiaalidation by real-time RT-PCR. Table 2 summarizes the
omparison of fold changes in expression for three represen-
ative genes after surgery, showing consistent changes between
aqMan quantitative PCR and microarray analysis.
estern blot analysis of tissue HIF1-alpha levels. The
IF1-alpha protein was examined in the adductor and calf
uscles (Fig. 3). In calf muscle, HIF1-alpha protein levels
ere elevated during the first three days after femoral artery
igation, whereas there was no evidence of HIF1-alpha
xpression through the study period in adductor muscle.
ISCUSSION
n this investigation, we have identified dynamic global
hanges of gene expression that occur in a region of active
igure 2. Expression profiles clustered according to similarity of tempora
pregulated genes whose peak expression occurred at 6 to 24 h after liga
ccurred at day 3. Late-phase induction includes upregulated genes whose
xpression was downregulated (0.5-fold). FAL  femoral artery ligation
able 2. Changes of Three Selected Genes Validated by
eal-Time RT-PCR (MCP1, MT1 at Day 1, and MMP12 at
ay 7)
Accession
No. Gene
Relative Ratios (Femoral
Artery Ligation/Sham)
Microarray RT-PCR
19681 MCP1 2.6 3.9
00835 MT1 3.6 4.2
82831 MMP12 2.9 3.2
CP1  monocyte chemoattractant protein-1; MMP12  metalloelastase (metal-
oproteinase-12); MT1  metallothionein-1; RT-PCR  reverse transcription-molymerase chain reaction.ollateral growth after induction of ischemia caused by
emoral artery ligation. Compared with a sham-operated
roup, a total of 783 genes in the femoral artery ligation
roup changed expression levels by at least two-fold at one
r multiple time points. Of course, we cannot be certain that
ll of these genes are related to collateral development and
hat portion of them are critical components of the re-
ponse. Furthermore, it is also possible that some of the
hanges in gene expression we found resulted from a
esponse to ischemia that has nothing to do with collateral
evelopment.
To further understand the potential role of ischemia in
nducing the gene expression changes we found, we char-
cterized the ischemic profile of the adductor muscle, the
issue used for RNA extraction. This was accomplished by
nalyzing the tissue for protein levels of HIF1-alpha, which
s mainly regulated post-translationally and is a critically
mportant cell sensor of hypoxia (4). Under normoxic
onditions, HIF1-alpha protein is ubiquitinated, which
argets the molecule for proteasome-mediated degradation.
hen the cell is exposed to hypoxia, ubiquitination no
onger occurs, and levels of HIF1-alpha protein are stabi-
ized. Therefore, tissue levels of HIF1-alpha provide a
arker of hypoxia/ischemia. Using this marker, we found
hat HIF1-alpha protein was not detectable in the adductor
ression patterns, using k-means cluster analysis. Early induction includes
Mid-phase induction includes upregulated genes whose peak expression
xpression occurred at days 7 to 14. Downregulation includes genes whosel exp
tion.
peak euscle, which lies proximally in the thigh. However,
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hree days after femoral artery ligation. In addition, HIF1-
lpha target genes relating to anaerobic energy metabolism
aldolase A, enolase 1, lactate dehydrogenase 1, phospho-
ructokinase, and phosphoglycerate kinase 1) showed no
ifference in expression in the adductor muscle between the
ham and ischemic groups (data not shown). Finally, West-
rn blotting showed no change in LDH1 gene expression in
he adductor muscle, compared with significant induction of
DH1 in calf muscle after femoral artery ligation (data not
hown).
Thus, the tissue we used for transcriptional profiling and
n which collaterals are developing demonstrated no overt
vidence of ischemia. These findings indicate that ischemia
lays either no or at most a minor role in the gene
xpression results we obtained. These results also support an
nteresting previously described finding—that collateral ves-
els developing proximal to an arterial obstruction do not
equire the local expression of either VEGF or HIF1 (5).
It is important to emphasize that our model is one in
hich collateral development has been well documented. In
he mouse model of hindlimb ischemia, immediately after
emoral artery ligation, a dramatic reduction in distal hind-
imb blood flow occurs, which progressively recovers over
ime (6). These findings have been observed using laser
oppler perfusion imaging to assess hindlimb blood flow
erfusion in the distal hindlimb and are well correlated with
icrosphere-assessed perfusion, as recently reported (7).
hus, an increase in flow after femoral artery ligation
Figure 3. Time course of hypoxia-inducible factor-1 (HIF-1) alpha expre
igure 4. Schematic summary of the time course of expression of selected
roups of genes after femoral artery ligation. IL  interleukin; IP 
nterferon-gamma-inducible protein; MCP  monocyte chemoattractant
rotein; MIP  macrophage inflammatory protein; MMP  metalloela-
tase (metalloproteinase).ccurs, and this increase in flow can only be due to an
ncrease in collaterals. In this regard, in the same report, it
as found that in the upper thigh, the number and size of
econd- and third-generation collateral branch arteries pro-
ressively increase after femoral artery ligation, changes that
orrelate with laser Doppler perfusion imaging-assessed
ow. Moreover, in a recent a report from our laboratory (8),
e evaluated the number of collaterals present within the
pper thigh (between muscle bundles and fibers) of wild-
ype C57BL/6 at baseline and 28 days after femoral artery
igation (same model as in the present investigation). A
ignificant increase in the density (number/surface area) of
ollaterals above baseline was observed in the operated leg of
57BL/6 mice (increase of 50%). Finally, Scholz et al. (9)
emonstrated that the adductor muscle is a site of active
rterial remodeling. Thus, we believe there exists compel-
ing evidence clearly indicating that collateral vessels develop
n the tissue we are examining for differential gene expres-
ion relating to collateral development (the adductor mus-
le), as shown by laser Doppler perfusion imaging for
ollateral perfusion, anatomic evidence of the presence of
ollaterals by several different techniques, and microsphere
ow determinations of collateral flow.
Overall, temporal patterns of gene expression after fem-
ral artery ligation can be schematically summarized as
hown in Figure 4. It is interesting to note the apparently
rominent role played by genes modulating inflammatory
esponses. We found numerous genes relating to inflamma-
ory responses differentially regulated, with many showing
xtremely high levels of transcriptional activity. The ENA-
8, indicative of early neutrophil infiltration (10), was
pregulated early after ischemia onset. Maximum levels of
CP1, which recruits monocytes, were reached by day 1
nd slowly declined thereafter. The interferon-gamma-
nducible protein-10 and MIG are T-cell attractants, and
heir expression peaked at day 7. The time course of
hemokine expression roughly correlated with the recruited
eukocyte markers, consistent with a previous report that
hemokines are sequentially expressed during wound heal-
ng (10). Interestingly, markers for mast cells (GP49,
P49b) were also detected, supporting a role for these cells
n arteriogenesis (11). The anti-inflammatory lipocortin-1
ene was induced late after femoral artery ligation, which
robably contributes to resolution of inflammation (12).
Although these finding relating to inflammation could be
in adductor and calf muscles after femoral artery ligation. C  control.ssion
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ncreasing evidence suggesting that components of inflam-
atory responses constitute critically important players in
he development of collateral vessels (13,14). Our results are
ot only compatible with such a concept, but also the
iversity of the response demonstrates the extraordinarily
omplex gene responses that are involved in arteriogenesis.
oreover, the sequential expression of pro-inflammatory
ollowed by anti-inflammatory genes suggests that inflam-
ation contributes to early processes, leading to the initia-
ion of collateral formation, but resolves soon after induc-
ion begins.
One of the mechanistically important findings of this
tudy which has not been previously described is the
ncreased expression of angiostatic genes (including IP-10,
IG, and MMP12) (15,16) at late time points after arterial
igation. The MMP12 is the most efficient angiostatin-
nducing MMP, and angiostatin is one of the most potent
ngiostatic factors (16). The relatively late appearance of
P-10, MIG, and MMP12 probably contributes to a late
hift in the processes involved in arteriogenesis, possibly
shering in a different phase of collateral formation, such as
phase relating to collateral maturation.
Endothelial cell survival is thought to be an essential
echanism during angiogenesis (17). We found that genes
nvolved in cytoprotection signaling (Hmox1, HSP70-3,
T1) were highly upregulated early after femoral artery
igation, indicating that ischemic stress may trigger a genetic
rogram for cell survival. In addition, evidence suggests that
mox1 and MT1 are involved in angiogenesis (18,19), a
onclusion compatible with our finding of the persistent
xpression of such genes into the mid-phase of gene
xpression after femoral artery ligation. Taken together,
mox1 and MT1 may affect endothelial cell survival in
ollateral-forming tissues and contribute to arteriogenesis.
A number of genes associated with cell structure and
xtracellular matrix modification are differentially expressed
uring the late time points, as were several isoforms of
ollagen, cathepsin S, MMPs, osteoblastic-specific factor-2,
nd osteopontin. These genes may contribute to collateral
evelopment in that an altered balance between extracellular
roteolysis and antiproteolysis is associated with growing
ollateral vessels (20).
Interestingly, aquaporins (Aq1, Aqp4) were significantly
epressed throughout the study period. Aquaporins are
ater channels that regulate transcellular water permeability
nd have been implicated in the process of edema formation
uring inflammation (21). In our model, Aqp4 repression
ay help to prevent excessive edema in the collateral-
orming tissues. However, their specific role in arteriogen-
sis remains unknown.
Finally, in the sham group, inflammation-related genes
ere also induced after surgery, suggesting that the sham
peration itself can induce a number of changes in gene
xpression. This finding highlights the importance of care-ully considering the optimal controls in gene expression
rofiling studies.
tudy limitations. A potential limitation of the study
eeds to be addressed. Specifically, the adductor muscle,
hich contains the proximal portions of the developing
ollateral vessels, was used for RNA extraction. The speci-
en necessarily contains a far greater proportion of skeletal
uscle tissue compared with collateral tissue. Therefore, we
annot at this time definitively distinguish between
ollateral-related differential gene expression and differential
ene expression that relates exclusively to the wound healing
esponse to our intervention.
Despite these limitations, we believe our study provides a
reliminary picture of global temporal patterns of gene
xpression involved in the complex processes contributing to
ollateral formation. These findings can serve as a genomic
odel for a more complete understanding of arteriogenesis
nd as a data base for the development of new therapeutic
trategies.
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